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Background: The aim of the study was to examine the reactivity of peripheral human leukocytes to various metal
ions prior and following hip replacement in order to investigate implant-induced metal sensitivity.
Methods: Three patient groups were set up: (1) individuals without implants and no history of metal allergy (7 cases),
(2) individuals without implants and known history of metal allergy (7 cases), and (3) patients undergoing cementless
hip replacement (40 cases). Blood samples were taken in groups 1 and 2 at three different occasions; in group 3, prior
and 3, 6, 12, 24, and 36 months after surgery. Peripheral leukocytes were separated and left either untreated or
challenged with Ti, NiCl2, CoCl2, CrCl3, and phytohemagglutinin. Cell proliferation, cytokine release, and leukocyte
migration inhibition assays were performed. Metal-induced reactivity was considered when all three assays showed
significant change. Skin patch tests were also carried out.
Results: Both skin patch tests and leukocyte functional tests were negative in group 1, and both were positive in
group 2. In group 3, after 6 months, 12% of the patients showed reactivity to the tested metals except for NiCl2.
Following the 36-month period, 18% of group three became sensitive to metals (including all the earlier 12%). In
contrast, patch tests were negative at each time point in group 3.
Conclusions: Orthopedic implant material may induce metal reactivity after implantation in a manner where
susceptibility is yet to be elucidated. Leukocyte triple assay technique might be a useful tool to test implant material-
related sensitivity.
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Joint replacement has become a routine procedure, over
1 million performed annually worldwide. Nowadays, the
predominant components of orthopedic implant mate-
rials are various metals. Due to continuous developing,
the up-to-date metal alloy endoprostheses have great
biomechanical and biocompatible properties. Implanted
metals, however, undergo corrosion, and various degrad-
ation products are released including metal ions [1,2].
These molecules can activate the immune system as
haptens by forming complexes with naturally occurring
proteins. Metal–protein complexes are potential anti-
gens inducing hypersensitivity responses (i.e., delayed* Correspondence: csabavermes@hotmail.com
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reproduction in any medium, provided the ortype, type IV, cell-mediated adoptive reactions). Nickel is
the most common metal sensitizer in humans followed
by cobalt and chromium and in a lesser extent titanium
also. Peripheral T lymphocytes get into contact with
metals, and a subpopulation of these cells (TH1) become
activated releasing different cytokines (tumor necrosis
factor-α (TNF-α), interferon-γ (IFN-γ), interleukin (IL)-
1, IL-2). This process recruits macrophages to the activat-
ing site, and a proinflammatory milieu develops. This may
affect negatively the biocompatibility and osteointegration
of joint implants [3-6].
Testing implant-related metal hypersensitivity is a spe-
cific task. Routinely, skin patch tests have been
performed for decades [7-9]. In this case, however, the
antigen-presenting cell is Langerhans cell in the skin,
which is not predominant within the periprostheticLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lymphocyte/monocytes) function as antigen-presenting
cells around orthopedic implants. Thus, the develop-
ment of various in vitro functional cell assays (prolifera-
tion, cytokine production, and migration inhibition
tests) performed on peripheral leukocytes became neces-
sary in order to gain insight into the implant-related
metal hypersensitivity reactions [10-14]. Metal degrad-
ation products besides their prominent local effects, may
cause remote problems, as metals and activated cell pop-
ulations invade the human body [15-18].
We hypothesized that metallic components of hip im-
plants can induce metal sensitivity in patients where
metal allergy earlier was not present. Our aim was to
examine the reactivity of human leukocytes to various
metals before and after hip replacement and detect pos-
sible implant-induced metal reactivity/allergy in a pro-
spective manner.Materials and methods
Patient groups
Three patient groups were established: (1) age-matched
patients without any implant and no history of metal
allergy tested via skin patch test analysis (7 cases: 4 male,
3 female, average age: 59 years), (2) age-matched
patients without any implant with a positive history of
metal hypersensitivity analyzed by skin patch test (7
cases: 3 male, 4 female, average age: 62 years), and (3)
patients undergoing cementless hip replacement with no
history of metal allergy prior the surgery (40 cases: 20
male, 20 female, average age: 61 years) analyzed by skin
patch testing and leukocyte functional testing (described
later). Informed consent was obtained from all subjects
after institutional review board review and approval. Im-
plants used in the study are comprised of a titanium-6%
aluminum-4%vanadium alloy stem with a cobalt–chro-
mium femoral head, an ultrahigh molecular weight poly-
ethylene acetabular liner in a titanium-6%aluminum-4%
vanadium alloy shell, and the patients had no other
implant.Sample collection and cell cultures
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from 20 ml of peripheral blood from peripheral
venipuncture using density gradient separation (Ficoll-
isopaque, Pharmacia, Piscataway, NJ, USA). Serum was
also collected. Ficoll-separated mononuclear cells consist
of mainly lymphocytes. Allergen-challenged lymphocytes
respond with increased proliferation, cytokine produc-
tion, and migration inhibition. Leukocytes in all assays
were incubated with Dulbecco’s modified Eagle’s medium
and 10% autologous serum [19].Treatment of cells
Leukocytes in all assays were incubated with either no
metal (plain media) as a negative control, 0.01 mg/ml
phytohemagglutinin (PHA) as a positive control, or
metal for 5 days. Metals used in the in vitro studies were
the more prevalent implant–alloy metals. The following
concentrations were applied: 0.1 mM CrCl3, 0.1 mM
NiCl2, 0.1 mM CoCl2 (Sigma, St. Louis, MO, USA) and
approximately 0.01 mM titanium (using culture medium
from incubated titanium beads) according to earlier rec-
ommendations [19,20]. The lower concentration of
titanium is due to the fact that this alloy has insoluble
property at physiologic pH and its subsequent inability
to form ions in solution; nonetheless, this would be
expected in vivo also [21].
Proliferation assay (lymphocyte transformation tests)
We used standard lymphocyte transformation testing
(LTT) protocol of mononuclear cells to measure
lymphocyte proliferation in a 96-well plate system, [3H]-
thymidine was added (1 mCi/culture well) during the
last 12 h of incubation after 4 1/ 2 days of treatment. At
day 5, [3H]-thymidine uptake was measured using liquid
scintillation beta plate analysis (Wallac Gatesburg, MD,
USA). The amount of [3H]-thymidine incorporation for
each metal treatment was compared to the non-treated
control resulting in a ratio, referred here as proliferation
rate. All the assays were performed in triplicates. The
time lag, associated with in vivo lymphocyte proliferation
in a delayed type hypersensitivity response, was simu-
lated in vitro for 5 days of incubation [10].
Cytokine analysis
Cytokine concentrations in supernatants of leukocyte cul-
tures were obtained after 48 h of incubation following
treatments. Levels of IFN-γ and tumor TNF-α were mea-
sured by enzyme-linked immunosorbent assays in 96-well
plates following the manufacturer’s instructions (assay
range from 0.5 to 32 pg/ml, R&D Systems, Minneapolis,
MN, USA and Sanquin, Amsterdam, Netherlands, all sup-
plied by Biotest Hungary Ltd., Budapest, Hungary) [20].
All the assays were performed in triplicates.
Leukocyte migration inhibition tests
The migratory capacity of PBMCs was assessed using a
modified Boyden chamber technique. Briefly, 4 × 105
cells were put in culture medium consisting 10% autolo-
gous serum and placed in the upper buffer chamber of a
24-well modified Boyden chamber (FluoroBok, BD Bio-
sciences, Franklin Lakes, NJ, USA). The upper chamber
was placed in the lower chamber containing plain medium
or culture medium supplemented with PHA or metal
treatments for 48 h at 37°C. Cells were then counted in
both chambers using a microscope to determine the
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performed in triplicates by one observer (C.V.).
Skin patch testing
Patch testing was performed using Finn chambers
(8 mm) on Scanpor tape (Almirall Hermal, Reinbek,
Germany). Nickel sulfate, cobalt chloride, chromium
chloride, and titanium oxalate were tested in petrolatum
in concentrations of 5%, 1%, and 0.5%, respectively,
according to international standards. The patch tests
were applied to the upper back and were occluded for
48 h. Readings were done on day 2, day 3, or day 4, and
day 7 according to the recommendations from the Inter-
national Contact Dermatitis Research Group. Homoge-
neous redness and infiltration in the entire test area
were scored as a 1+ reaction. Homogeneous redness,
infiltration, and vesicles in the test area were scored as a 2
+ reaction, and homogeneous redness, infiltration, and co-
alescing vesicles in the test area were scored as a 3+ reac-
tion. A 1+, 2+, or 3+ reading was interpreted as a positive
response. An irritant response, a doubtful, or a negative
































Figure 1 The effect of various metals and PHA on the proliferation ra
Co 0.1 mM, Cr 0.1 mM, Ni 0.1 mM) and PHA (0.1 mg/ml) on the proliferatio
untreated or treated as indicated. (a) (unreactive), it is clearly demonstrated
and after the surgery. (b) (reactive), however, Co, Cr and Ti increased the p
patients) of group 3, which was increased up to 35% (14 patients) after 36
patients in group 3. Positive control PHA increased proliferation significantl
significance is shown, *p < 0.05. Note that Ni did not influence proliferationStatistical analysis
First, the distribution of the data was assessed (Kolmo-
gorov–Smirnov test). Normally distributed data (LTT
analysis) were subjected to statistical analysis using Stu-
dent’s t tests. Student’s t tests for independent samples
with unequal or equal variances were used to test equal-
ity of the mean values at a 95% confidence interval
(p < 0.05). In case of not normally distributed samples
(cytokine and migration inhibition assays) the Kruskall–
Wallis non-parametric analysis of variance test was used.
Subsequently, the Wilcoxon–Mann–Whitney test was
used when the Kruskall–Wallis test showed significant
change. Treatment-specific responders were selected
based on a statistically significant 1.5 fold change in the
selected assay (p < 0.05) [19].
Results
Proliferation assay
Positive control PHA induced significantly (p < 0.05) in-
creased proliferation rate in all patient groups along the
study. In group 1, among the metals tested, only Ni






























te of patients’ leukocytes. The effect of various metals (Ti 0.01 mM,
n rate of patients’ leukocytes in group 3 is shown. Cells were
that metal challenge did not influence cellular proliferation before
roliferation rate significantly 6 months after surgery in 25% (10
months, distinguishing a subgroup referred here as metal sensitive
y in each experiment. Columns represent means + SD, level of
significantly.
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lected based on positive skin patch metal allergy tests
for all Ni, Co, Cr, and Ti, in the presence of these metals,
proliferation rate was significantly (p < 0.05) elevated as
expected. In group 3, before the surgery, none of the
samples responded to metal challenge. After 6 months,
25% (n = 10) of the patients showed significantly higher
proliferation rate in the presence of metals except for
Ni. Even Ti, which was used in lower concentration,
showed stimulation. Following the 36-month period,
35% (n = 14) become sensitive to metals (Figure 1).
Interestingly, during the study, patch test was negative at
each time point for all the metals tested in every patient.
Cytokine production
Positive control PHA induced significantly (p < 0.05) in-
creased secretion of IFN-γ and TNF-α in all patient
groups along the study. In group 1, none of the metals
tested stimulated cytokine production. In group 2, where
patients were selected based on positive skin patch metal
allergy tests for Ni, Co, Cr, and Ti, in the presence of



































Figure 2 The effect of various metals and PHA on IFN-γ production o
0.1 mM, Cr 0.1 mM, Ni 0.1 mM) and PHA (0.1 mg/ml) on IFN-γ production
treated as indicated. (a) (unreactive) it is clearly demonstrated that metal ch
after the surgery. (b) (reactive) however, Co, Cr, and Ti increased the IFN-γ
group 3, which was increased up to 30% (12 patients) after 36 months, dis
group 3. Positive control PHA increased IFN-γ production significantly in ea
shown, *p < 0.05. Note that Ni did not influence IFN-γ secretion significantlelevated in all patients. In group 3, before the surgery,
none of the samples responded to metal challenge. After
3 months, 21% (n = 8) of the patients showed signifi-
cantly higher secretion of IFN-γ and TNF-α in the pres-
ence of metals; Ni increased these parameters only
modestly. Even Ti showed activation. Following the
36-month period, 30% (n = 12) of patients’ samples
showed increased IFN-γ and TNF-α production in vitro
(Figure 2 and 3). Again, patch test was negative at each
time point for all the metals in every patient.
Leukocyte migration inhibition
In group 1, metals did not modify the ability of
leukocyte to actively migrate. In group 2, leukocytes
showed inhibited migration in the presence of each
metals used in the study. In group 3, before the surgery,
none of the samples responded to metal challenge. After
6 months, 16% (n = 6) of the samples showed signifi-
cantly altered migration of PBMCs in the presence of
metals. Following the 36-month period, 23% (n = 9) of
patients’ samples showed significantly changed leukocyte






























f patients’ leukocytes. The effect of various metals (Ti 0.01 mM, Co
of patients’ leukocytes in group 3 is shown. Cells were untreated or
allenge did not influence significantly the cytokine release before and
secretion significantly 3 months after surgery in 21% (8 patients) of
tinguishing a subgroup referred here as metal-sensitive patients in



























































Figure 3 The effect of various metals and PHA on TNF-α production of patients’ leukocytes. The effect of various metals (Ti 0.01 mM, Co
0.1 mM, Cr 0.1 mM, Ni 0.1 mM) and PHA (0.1 mg/ml) on TNF-α production of patients’ leukocytes in group 3 is shown. Cells were untreated or
treated as indicated. (a) (unreactive) it is clearly demonstrated that metal challenge did not influence significantly the cytokine release before and
after the surgery. (b) (reactive) however, Co, Cr, and Ti increased the TNF-α secretion significantly 3 months after surgery in 21% (8 patients) of
group 3, which was increased up to 30% (12 patients) after 36 months, distinguishing a subgroup referred here as metal-sensitive patients in
group 3. Positive control PHA increased TNF-α production significantly in each experiment. Columns represent means + SD, level of significance
is shown, *p < 0.05. Note that Ni did not influence TNF-α secretion significantly.
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The results of functional leukocyte assays revealed
reactivity to metals following hip replacement. Different
assays, however, showed various fractions of group 3
which became sensitive to metals listed above. The
reactive ratio of group 3 varied also by exposure time (3
months vs. 36 months). Thus, a patient was considered
reactive when all three assays showed significant
(p < 0.05) changes. Based on these criteria, 12% (n = 5)
and 18% (n = 7) fraction were found reactive after 6 and
36 months, respectively, following surgery in group 3.
The 12% portion was among the latter 18% fraction. All
of the hip implants had good functions (average Harris
Hip Score: 92), and none of them needed revision (no
osteolysis on the X-ray) along the follow-up of the study.
Discussion
Dermal hypersensitivity to different metals is well docu-
mented and affects approximately 10–12% of the general
population. Nickel is the most common metal sensitizer
in humans followed by cobalt and chromium and vari-
ous responses have been reported to titanium as well,and cross-reactivity between nickel and cobalt is known.
If metal sensitivity is known prior to implantation, spe-
cific implant components can be chosen [3,23-25].
The prevalence of metal sensitivity among patients with
well-functioning and poorly functioning implants has been
reported to be approximately 20% and 50%, respectively,
as measured by dermal patch testing [3,7,8,23]. It was pro-
posed that skin testing may not be the most appropriate
method to test orthopedic implant-related metal sensitiv-
ity; thus, different in vitro functional assays performed on
peripheral leukocytes have been developed and found even
higher occurrence of metal sensitivity [9,14,21,26].
Using the combination of these assays, we found that
18% of patients became sensitive to metals 36 months
after cementless hip replacement with well-functioning
implants. Earlier, other studies using leukocyte assays
have reported a larger fraction of patients to be sensitive
to metals with well-functioning implants. The discrep-
ancy is likely due to the different methods by which
metal sensitivity was tested and the various time periods
following surgery when the tests were carried out. The
latter seems to be important because our study showed
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vs. 36 months), the greater proportion of the cohort was
found sensitive (12% vs. 18%). A patient was referred here
to be reactive to a metal when all the tests applied in this
study showed significant results at the maximum pro-
spective follow-up time of 36 months. Many other studies,
however, are not prospective, lacking the information
about the prevalence of metal sensitivity in the cohort
prior the operation, and mainly apply one method to
analyze lymphocyte/leukocyte reactions at a long time
period following surgery [19,21,26]. Taken together, we be-
lieve that combining the results of leukocyte assays is a
stricter method to consider a sample reactive. This may
lead to a more useful screening process to select patients
with implant metal-induced sensitivity.
Patients with well-performing hip implants showed a
higher incidence of metal reactivity, as determined by
leukocyte assays than that of healthy controls. Interest-
ingly, even Ti induced significant reactions, although in
a lesser magnitude. Importantly, Ni did not induce
leukocyte reaction along the study, which may be
expected as implants applied did not contain Ni, show-
ing that the measured reactivity to various metals were
implant component specific. It seems that hip replace-
ment procedure can sensitize patients’ leukocytes. Al-
though the relationship between leukocyte assays and
total hip arthroplasty clinical outcome remains undeter-
mined, these results are consistent with the idea of individ-
ual susceptibility for hypersensitivity to metal components
from implant degradation. The mechanism of such suscep-
tibility and the clinical significance of these findings are yet
to be determined because the long-term clinical perform-
ance of hip implants in a sensitized population and genetic
background of individual responsiveness to metals are un-
known to date.
Various immune responses to degradation products
from implant materials can compromise the longevity of
joint replacement [1,2,18,19]. Wear debris from bearing
surfaces are generated continuously and phagocytosed
by different cell types in the periimplant area inducing
proinflammatory cascade in the periprosthetic space
leading to the activation of osteoclasts and suppression
of osteoblasts which in turn result in periprosthetic oste-
olysis, a process known as aseptic loosening of implants
[1,27,28]. Lymphocytes can react with metals and medi-
ate adoptive, cell-mediated delayed type hypersensitivity
reaction. This seems to be TH1-type reaction as earlier
studies proposed [19-21]. Our investigation also support
this result as PBMCs, which contain approximately 85%
lymphocytes, from patients with hip implants showed in-
creased proliferation rate, TH1-type cytokine production
and migration inhibition. Activated lymphocytes express
mediators (e.g., receptor activator of nuclear factor
kappa-B ligand) that ultimately leads to osteoclastactivation. This mechanism alone may jeopardize the suc-
cess of joint replacement and can worsen wear debris-
induced aseptic implant loosening [29].
Conclusions
Total joint replacement procedure may induce metal
sensitivity in patients where metal allergy was not
present earlier. This reaction can be revealed using spe-
cific in vitro cellular analyses. The result of combined
leukocyte assays can be a useful tool to test implant
material-related reactivity and may be superior to patch
testing. These tests, however, are only capable of deter-
mining the presence of metal sensitivity following hip
replacement, which provides the possibility only for sec-
ondary or tertiary prevention. The long-term signifi-
cance of the present study by following the reactive
patient group is that we will have data on the functions
of these implants and compare metal sensitivity suscep-
tible and non-susceptible patient groups in order to
develop a diagnostic tool. In the future, one can envision
a screening process where susceptibility for orthopedic
implant-induced metal hypersensitivity can be determined
before joint replacement providing possibility for primary
prevention.
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